Untitled Document
Untitled Document
Untitled Document
When a pregnant woman takes psychotropic medications during pregnancy, how does the
medication reach the fetus?
All psychotropic drugs presumably cross the placenta and are present in the amniotic fluid.
• Miscarriage
• Major and minor structural malformations
• Fetal growth restriction and low birth weight
• Preterm delivery
• Neonatal toxicity and withdrawal
• Postnatal developmental effects upon behavior, cognition, and emotional regulation
Pregnancy Category B - Studies carried out on animals have shown no adverse effects on the
fetus; however, there is a lack of controlled studies on human pregnancy.
Pregnancy category C -Animal studies have shown evidence of harmful effects on the
fetus;however, no controlled study has been done on a human pregnancy. The medicines may
beprescribed in cases where the potential benefits outweigh the possible adverse effects.
Pregnancy category D -Studies done on human pregnancy have shown positive risks to the
fetus. However, doctors might prescribe them in certain cases where the potential benefits
outweigh the risks.
Pregnancy category X - Both human and animal studies have shown positive risks to the
fetus,with the adverse effects extending to serious birth defects, miscarriage and fetal death.
Thepossible risks of using these medicines outweigh any potential benefits.
Formation of:
- Neural tube closure ≤ 4.5 weeks
- Heart/great vessels 3-8 weeks
- Lip/palate 6-9 weeks
Known risks of mental disorder must be weighed against largely unknown risks of medication
What should you know about psychotropic medications and breast feeding?
The post-partum period is a high-risk time for onset/relapse/recurrence ofmental disorders.
Babies can be genetically slow (or fast) metabolizers: in utero exposure toenzyme inhibitors (or
inducers) can affect metabolism
Generally, total dose of drug ingested via breast mild is quite small.
• Valproate
• Carbamazepine
• Lithium
• Lamotrigine
• Antipsychotics
• Antidepressants
• Venlafaxine
What are the risk or taking antidepressants during pregnancy related to neonatal
toxicity/withdrawal?
SSRI discontinuation syndrome: observed in offspring of mothers who used SSRI-type
antidepressants during third trimester
• Rarely, convulsions
• Occurs in 30 of exposed neonates
• Symptoms are usually mild and gone by 2 weeks of age
• A severe syndrome with seizures, dehydration, excessive weight loss, hyperpyrexia and
intubation in 1/313 cases
What are the guidelines for the use of antidepressants during pregnancy?
Medication is first line treatment only if -> Depression is severe -> The likelihood for
relapse/recurrence is high
• May be preferred
• Citalopram may be less desirable because of the potentially high breast milkconcentration
What are the risk for untreated bipolar disorder in pregnant women?
Untreated maternal mood disorders are serious risk factors for the fetus.
• Lamotrigine (Lamictal): not considered a major teratogen, slight increase risk for cleft
lip/palate.
What supplements should pregnant women be prescribed when taking Valproic Acid during
pregnancy?
All women of childbearing potential who are prescribed VPA should receive folate
supplementation (4-5 mg/day)
Folate supplementation, from preconception through the 1st trimester,decreases the risk of
neural tube defects generally, but has not been tested in women taking antiepileptic drugs.
What are the neonatal toxicity risks for taking valproic acid in pregnancy?
• Heart rate decelerations
• Hepatotoxicity
• Hypoglycemia
What supplements should pregnant women be prescribed when taking Carbamazepine during
pregnancy?
Women on CBZ during pregnancy should receive vitamin K, 20mg/day during the last month to
prevent fetal prenatal bleeding
• Symptoms typically subside within hours to days, but may persist for weeks to months after
birth.
• Specific treatment is usually not necessary, but more severely affected newborns may require
longer hospital stays